Low-Dose Triple Combination Pill Effective for Hypertension Control, finds study Written By Jacinthlyn Sylvia20 April 2026 10:45 AM ISTA study published in the Journal of the American College of Cardiology found that a single-pill low-dose combination of amlodipine, losartan, and...
The ACC 2026 Updates on Redefining Hypertension Management: Translating Evidence on End Organ Protection Written By Dr. Kamal Kant Kohli16 April 2026 12:00 PM ISTFollowing the conclusion of American College of Cardiology (ACC) 2026 conference held between March 28-30, 2026, New Orleans, LA, United States), a...
State Drug Alert: 147 Medicine Samples Fail CDSCO Quality Tests in January 2026 Written By Susmita Roy25 Feb 2026 1:38 PM ISTNew Delhi: Highlighting continuing concerns over medicine quality, the Central Drugs Standard Control Organisation (CDSCO) has released its January...
From Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing Reforms Written By Susmita Roy7 Feb 2026 9:53 PM ISTNew Delhi: In an alarming indictment of India's pharmaceutical pricing system, the Parliamentary Standing Committee on Chemicals and Fertilizers has...
NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, Details Written By Susmita Roy6 Nov 2025 11:38 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of...
Amlodipine Linked to Lower Acute Infection Rates Compared to Ramipril or Bendroflumethiazide: Study Written By Dr Riya Dave8 Oct 2025 9:15 AM ISTA new study published in the Journal of American Heart Association has revealed that new users of amlodipine for hypertension had lower rates of acute...
Piramal Pharma Solutions, George Medicines develop new hypertension drug Widaplik Written By Ruchika Sharma31 Aug 2025 11:30 AM ISTMumbai: George Medicines, a late-stage biopharma company, in partnership with Piramal Pharma Solutions (PPS), a global Contract Development and...
State Drug Alert: Ciprofloxacin, Lorazepam, Albendazole Among 97 NSQ Samples Flagged in July Susmita Roy29 Aug 2025 5:12 PM ISTNew Delhi: Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...
Racket manufacturing fake medicines busted, factory owner held Written By Ruchika Sharma19 July 2025 5:05 PM ISTDehradun: The owner of Dr Mittal Laboratories, which manufactured fake medicines by copying products of reputed pharmaceutical companies, was...
Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD Written By Dr. Nandita Mohan20 Jun 2025 12:00 PM ISTIn a first move Ajanta pharma one of the leaders in the cardiology segment, has announced the launch of Met XL AMT 25 mg. It is a triple-drug...
FDA Approves First Triple-Drug Polypill for Initial Hypertension Treatment Prem Aggarwal13 Jun 2025 9:15 AM ISTThe FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of hypertension in adults, including as...
Alembic Pharma bags USFDA nod for high BP traetment drug Written By Ruchika Sharma23 May 2025 3:29 PM ISTVadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for Amlodipine...
